The U.S. pulse and regional oximeters market is expected to demonstrate a CAGR of 8.2% between 2019 and 2024, owing to the presence of prominent players and large-scale use of pulse and regional oximeters for health monitoring across the nation. Additionally, the rising number of patients opting for metabolic screening, increasing number of medical centers and hospitals, and soaring public awareness about surgical care programs will also facilitate the industry growth. Therefore, the market revenue is expected to reach $1,101.4 million by 2024.
In recent years, the increasing number of collaborations and acquisitions among industry players have become a prominent trend in the U.S. pulse and regional oximeters market. Key players are engaging in collaborations and acquisitions to expand their customer base, product portfolio, and footprints. For example, in April 2019, Edwards Lifesciences Corporation completed the acquisition of CAS Medical Systems Inc. (CASMED) for $100 million. With this move, Edwards aimed to use FORE-SIGHT non-invasive cerebral oxygenation technology of CASMED and to pair FORE-SIGHT technology of CASMED with its HemoSphere advanced hemodynamic monitoring platform.
In contemporary times, major players in the U.S. pulse and regional oximeters industry are focusing on strategic measures, such as regulatory approvals and product launches, to stay ahead of their competitors. For instance, in August 2015, Nonin Medical Inc. unveiled Apple iOS mobile app and NoninConnect model 3230 Bluetooth smart wireless finger pulse oximeter for patients and clinicians outside the U.S. Other key players adopting such strategic measures include Edwards Lifesciences Corporation, Masimo Corporation, and General Electric Company.
